SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-268644
Filing Date
2017-08-25
Accepted
2017-08-25 16:09:20
Documents
4
Effectiveness Date
2017-08-25

Document Format Files

Seq Description Document Type Size
1 S-8 d430439ds8.htm S-8 40612
2 EX-5.1 d430439dex51.htm EX-5.1 6458
3 EX-23.1 d430439dex231.htm EX-23.1 1323
4 GRAPHIC g430439g0824012034677.jpg GRAPHIC 2507
  Complete submission text file 0001193125-17-268644.txt   53040
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-220172 | Film No.: 171052081
SIC: 2834 Pharmaceutical Preparations